Yes, I’m happy to give him that assurance. In fact, yesterday we published the CARIS data, I’ll tell you what that is—It’s the Congenital Anomaly Register and Information Service. Now, we established that in Wales in 1998, and that is part of what helps us to lead the field. It maintains information on all babies born to mothers in Wales, and that information is held about them if they do have a congenital anomaly or a rare disease until their eighteenth birthday, or when they would have reached their eighteenth birthday. It’s part of looking at that data and information that allows us to try and make further progress. We’re also taking part, with the rest of the UK, in the 100,000 Genomes Project, and have invested directly money within that. And, of course, the monies we’re investing in the new treatment fund—chunks of that money will go to treating people with rare diseases and conditions. So, I’m more than happy to give him the assurance this will continue to be an area of interest and action, and we expect to see further improvement.